Alpha Emitter Market, By Type of Radionuclide (Radium, Actinium, and Lead ), By Medical Applications, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023

Description

Alpha emitters play a significant role in the treatment of different types of cancer. Targeted alpha therapy (TAT) is a therapeutic option in patients with multiple micro-metastases. Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancer. Properties of alpha emitters have led to exert profound differences between this field and other fields of nuclear medicine.

Market Dynamics:

Increase in burden of cancer, rise in geriatric population, increase in use of targeted alpha therapy (TAT) for cancer treatment, rise in awareness about the potential benefits of TAT, and increase in research and development are expected to propel the growth of the global alpha emitter market.

For instance, in July 2021, Alpha Tau Medical Ltd. and Healthcare Capital Corporation signed an agreement to further expand Alpha Tau's clinical strategy, including the pursuit of FDA (Food and Drug Administration) marketing authorization, a broad array of R&D (research and development) activities, expanding manufacturing capacity, and preparing for commercialization.

Key features of the study:

This report provides in-depth analysis of the global alpha emitter market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global alpha emitter market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Bayer AG, Alpha Tau Medical Ltd., Fusion Pharmaceuticals, Telix Pharmaceuticals, Orano Group (Orano Med), NOVARTIS AG (Endocyte Inc.), and Actinium Pharmaceutical Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global alpha emitter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alpha emitter market.

Detailed Segmentation:

Global Alpha Emitter Market, By Type of Radionuclide:
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
Global Alpha Emitter Market, By Medical Applications:
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Other Medical Applications
Global Alpha Emitter Market, By Geography:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Company Profiles:
- Bayer AG
- Alpha Tau Medical Ltd.
- Fusion Pharmaceuticals
- Telix Pharmaceuticals Ltd.
- Orano Group (Orano Med)
- NOVARTIS AG (Endocyte Inc.)
- Actinium Pharmaceutical Inc.

Product Code: CMI5534

Market Dynamics
- Rise in burden of cancer and rise in geriatric population
- Stringent regulations and need for high capital investment
- Increase in adoption/use of targeted alpha therapy (TAT)
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Alpha Emitter Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Alpha Emitter Market, By Type of Radionuclide, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Radium (Ra-223)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Actinium (Ac-225)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Lead (Pb-212)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Alpha Emitter Market, By Medical Applications, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Bone Metastases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Ovarian Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Pancreatic Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Endocrine Tumors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Other Medical Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Alpha Emitter Market, By Geography, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Applications, 2017-2030,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Applications, 2017-2030,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Applications, 2017-2030,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Applications, 2017-2030,(US$ Mn)
Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Applications, 2017-2030,(US$ Mn)

8. Competitive Landscape

Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alpha Tau Medical Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fusion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Telix Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Orano Group (Orano Med)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NOVARTIS AG (Endocyte Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Actinium Pharmaceutical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

Alpha Emitter Market, By Type of Radionuclide (Radium, Actinium, and Lead ), By Medical Applications, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Description

Table of Contents

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents:

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis